Category: Disease States

Disease States

Summary: CND Life Sciences has released baseline results from its NIH-funded Syn-Sleep Study,...

SAGA Diagnostics has launched Pathlight, a groundbreaking multi-cancer blood test for ultra-sensitive detection of MRD.

Innovative IVF techniques are emerging to improve implantation predictions through non-invasive, AI-driven metabolomics assays.

The FDA has approved Roche’s VENTANA MET (SP44) RxDx Assay, the first companion diagnostic for lung cancer.

Researchers are uncovering how the deadly parasite E. histolytica kills human cells and evades the immune system.

hc1 has launched HerCare, a new module in its MyBloodHealth platform, to enhance maternal health by providing real-time lab-driven insights.

A new peer-reviewed study validates Vibrant Sciences’ microarray, enabling fast, accurate, scalable detection of over 17 tickborne pathogens.

University of Tokyo researchers have developed a non-invasive, AI-powered imaging system that tracks platelet activity in real time.

Alamar Biosciences has expanded its NULISAseq CNS Disease Panel 120 to include highly sensitive, blood-based assays.

The FreeStyle Libre continuous glucose monitoring system significantly reduces hospitalizations for cardiovascular complications.

Researchers developed a surgical face mask embedded with a breath sensor that can non-invasively detect chronic kidney disease (CKD).

The Cystic Fibrosis Base assay has received IVDR accreditation, ensuring high standards for detecting cystic fibrosis mutations.

Vail Scientific, in partnership with Minnetronix, has unveiled a newly designed VSNO sepsis screening device that enhances usability.